Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 19, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 19, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 21, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 20, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 19, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 12, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 12, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 6, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 4, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 4, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 4, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 14, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 12, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 12, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 11, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 11, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 11, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 14, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 12, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 12, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 12, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 26, 2017 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Sep 25, 2017 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Sep 25, 2017 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Sep 12, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 1, 2017 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Aug 2, 2017 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Aug 2, 2017 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Aug 2, 2017 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Aug 18, 2016 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Jul 16, 2016 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Jul 13, 2016 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Jun 28, 2016 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| May 18, 2016 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Apr 11, 2016 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Mar 29, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 29, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 9, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 22, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 17, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 16, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 16, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 10, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 4, 2016 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Feb 3, 2016 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jan 23, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, immune system diseases and disorders, autoimmune system diseases, and blood disorders, none of the foregoing related to oncology
Class 042
Research and development in the pharmaceutical and biotechnology fields, none of the foregoing related to oncology
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTHERAPEUTICS"